181 related articles for article (PubMed ID: 15541842)
21. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
Tarantini L; Cioffi G; Di Lenarda A; Valle R; Pulignano G; Del Sindaco D; Frigo G; Soravia G; Tessier R; Catania G
G Ital Cardiol (Rome); 2008 Dec; 9(12):835-43. PubMed ID: 19119693
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
23. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
[TBL] [Abstract][Full Text] [Related]
24. Prospective validation of the prognostic usefulness of B-type natriuretic peptide in asymptomatic patients with chronic severe aortic regurgitation.
Pizarro R; Bazzino OO; Oberti PF; Falconi ML; Arias AM; Krauss JG; Cagide AM
J Am Coll Cardiol; 2011 Oct; 58(16):1705-14. PubMed ID: 21982316
[TBL] [Abstract][Full Text] [Related]
25. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
[TBL] [Abstract][Full Text] [Related]
26. Significance and utility of plasma brain natriuretic peptide concentrations in patients with idiopathic ventricular arrhythmias.
Tada H; Ito S; Shinbo G; Tadokoro K; Ito I; Hashimoto T; Miyaji K; Kaseno K; Naito S; Nogami A; Oshima S; Taniguchi K
Pacing Clin Electrophysiol; 2006 Dec; 29(12):1395-403. PubMed ID: 17201848
[TBL] [Abstract][Full Text] [Related]
27. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
[TBL] [Abstract][Full Text] [Related]
28. Prognostic effect of long-axis left ventricular dysfunction and B-type natriuretic peptide levels in asymptomatic aortic stenosis.
Lancellotti P; Moonen M; Magne J; O'Connor K; Cosyns B; Attena E; Donal E; Pierard L
Am J Cardiol; 2010 Feb; 105(3):383-8. PubMed ID: 20102953
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of repeated versus single N-terminal pro B-type natriuretic peptide measurements early after-myocardial infarction.
Sandhu S; Har BJ; Aggarwal SG; Kavanagh KM; Ramadan D; Exner DV;
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S86-9. PubMed ID: 19250120
[TBL] [Abstract][Full Text] [Related]
30. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
[TBL] [Abstract][Full Text] [Related]
31. Changes in B-type natriuretic peptides after surgical ventricular restoration.
Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
[TBL] [Abstract][Full Text] [Related]
32. Preoperative plasma B-type natriuretic peptide (BNP) identifies abnormal transthoracic echocardiography in elderly patients with traumatic hip fracture.
Pili-Floury S; Ginet M; Saunier L; Besch G; Bartholin F; Chopard R; Boillot A; Mebazaa A; Samain E
Injury; 2012 Jun; 43(6):811-6. PubMed ID: 22029947
[TBL] [Abstract][Full Text] [Related]
33. Impact of Serial B-Type Natriuretic Peptide Changes for Predicting Outcome in Asymptomatic Patients With Aortic Stenosis.
Henri C; Dulgheru R; Magne J; Caballero L; Laaraibi S; Davin L; Kou S; Voilliot D; Nchimi A; Oury C; Pierard LA; Lancellotti P
Can J Cardiol; 2016 Feb; 32(2):183-9. PubMed ID: 26371385
[TBL] [Abstract][Full Text] [Related]
34. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction.
Price JF; Thomas AK; Grenier M; Eidem BW; O'Brian Smith E; Denfield SW; Towbin JA; Dreyer WJ
Circulation; 2006 Sep; 114(10):1063-9. PubMed ID: 16940194
[TBL] [Abstract][Full Text] [Related]
35. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.
Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Bickel C; Lackner KJ; Cambien F; Tiret L; Münzel T; Blankenberg S
J Am Coll Cardiol; 2006 Feb; 47(3):552-8. PubMed ID: 16458135
[TBL] [Abstract][Full Text] [Related]
36. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure.
Parekh N; Maisel AS
Curr Opin Cardiol; 2009 Mar; 24(2):155-60. PubMed ID: 19532102
[TBL] [Abstract][Full Text] [Related]
37. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
[TBL] [Abstract][Full Text] [Related]
38. B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin for Risk Stratification in Low-Flow, Low-Gradient Aortic Stenosis: A Substudy of the TOPAS Study.
Dahou A; Clavel MA; Capoulade R; O'Connor K; Ribeiro HB; Côté N; Le Ven F; Rodés-Cabau J; Dumesnil JG; Mathieu P; Pibarot P
JACC Cardiovasc Imaging; 2018 Jul; 11(7):939-947. PubMed ID: 28917673
[TBL] [Abstract][Full Text] [Related]
39. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
